Synapse - Paul Paik

Results (256)

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Journal Article

Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
Annals of Oncology (2018)

Fulltext@MSK | Save

YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics

Journal Article

Fan, P. D.; Narzisi, G.; Jayaprakash, A. D.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Yu, H. A.; Jordan, E. J.; Paik, P. K.; more...
Proceedings of the National Academy of Sciences of the United States of America (2018)

Fulltext@MSK | Save

Identifying the optimal radiation dose in locally advanced non-small-cell lung cancer treated with definitive radiotherapy without concurrent chemotherapy

Journal Article

Sonnick, M. A.; Oro, F.; Yan, B.; Desai, A.; Wu, A. J.; Shi, W.; Zhang, Z.; Gelblum, D. Y.; Paik, P. K.; Yorke, E. D.; more...
Clinical Lung Cancer (2018)

Fulltext@MSK | Save

OncoKB: A precision oncology knowledge base

Journal Article

Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
JCO Precision Oncology (2017)

Fulltext@MSK | Save

Response to osimertinib following treatment with EGF816 in patients with T790M EGFR mutant NSLCLC

Meeting Abstract

Arbour, K. C.; Sequist, L. V.; Piotrowska, Z.; Kris, M. G.; Paik, P. K.; Ni, A.; Plodkowski, A.; Riely, G.; Yu, H. A.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Phase II trial of the c-Met inhibitor tepotinib in advanced lung adenocarcinoma with MET exon 14 skipping mutations after failure of prior therapy